Skip to Content

Drug Interactions between Orthoclone OKT3 and Stribild

This report displays the potential drug interactions for the following 2 drugs:

  • Orthoclone OKT3 (muromonab-cd3)
  • Stribild (cobicistat/elvitegravir/emtricitabine/tenofovir)

Edit list (add/remove drugs)

Interactions between your drugs

There were no interactions found in our database between Orthoclone OKT3 and Stribild - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Orthoclone OKT3

A total of 99 drugs are known to interact with Orthoclone OKT3.

Stribild

A total of 504 drugs are known to interact with Stribild.

Drug and food interactions

Moderate

elvitegravir food

Applies to: Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)

Food significantly increases the absorption of elvitegravir. You should take each dose of elvitegravir with a meal. Taking it on an empty stomach may lead to inadequate blood levels and reduced effectiveness of the medication in treating HIV infection.

Switch to professional interaction data

Minor

tenofovir food

Applies to: Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)

Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.

For clinical details see professional interaction data.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide